Zura Bio (ZURA) 2025 Conference September 04, 2025 02:45 PM ET Speaker2Alright, we're ready to get started. Welcome, everyone, and thanks for tuning in. This is Josh Schimmer from the Cantor Biotech Equity Research Team, joined by Mai Ringer in hidradenitis suppurativa, Imogen Mansfield, who's done extensive work in understanding this disease. Together, we're welcoming Zura Bio, Robert Lisicki, Chief Executive Officer. Robert, welcome. Maybe start with a snapshot of the company and your lead program tibuliz ...